Stay updated on Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page.

Latest updates to the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page
- Check3 days agoChange DetectedNew navigation items were added for How to Read a Study Record, Common Questions, and How to Join a Study, and the Intervention/Treatment label was introduced. The old Intervention / Treatment label and the prior revision note (v3.5.5) were removed.SummaryDifference0.5%

- Check10 days agoChange DetectedThe page's revision tag was updated from Revision: v3.5.4 to Revision: v3.5.5, indicating a newer edition of the page was published.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedRevision metadata on the page was updated from v3.5.3 to v3.5.4, signifying a new version of the page. There are no changes to the study content or user-facing data indicated by this update.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page’s footer/site release revision was updated from v3.5.2 to v3.5.3, indicating a platform or template version change rather than a modification to the study record.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2; no other page content changes are indicated.SummaryDifference0.1%

- Check89 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0. No study content or core page functionality appears to be altered.SummaryDifference0.1%

Stay in the know with updates to Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page.